Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,212,806
-
Share change
-
+31,212,806
-
Total reported value
-
$247,729,000
-
Price per share
-
$7.69
-
Number of holders
-
34
-
Value change
-
+$240,039,000
-
Number of buys
-
33
Institutional Holders of POINT BIOPHARMA GLOBAL INC - COM (PNT) as of Q3 2021
As of 30 Sep 2021,
POINT BIOPHARMA GLOBAL INC - COM (PNT) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,212,806 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, FARALLON CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, and Fairmount Funds Management LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.